# Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting

> **NCT06762587** · NA · NOT_YET_RECRUITING · sponsor: **Capital Medical University** · enrollment: 372 (estimated)

## Conditions studied

- Influenza
- Influenza Prophylaxis
- Nosocomial Infection

## Interventions

- **DRUG:** Baloxavir Marboxil
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT06762587
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-05
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-05
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2025-01-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06762587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06762587, "Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06762587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*